Looking for the best protein powder? Our guide highlights the top picks for weight loss, women, budget, and more, tested and ...
We talked with nutrition experts and researched what goes into making the best protein powder for seniors. Learn more about ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...
Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...
According to my smart phone I walk about 8200 steps, or about four miles, every day when I’m on the golf course. That translates to about four miles. According to my phone’s health app, I burned only ...
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It may be fewer injections. Limited time: Save 25% on NBC News subscription Get exclusive reporting, ...
Coverage for Ozempic and other drugs used for weight loss has fast become one of the most coveted workplace benefits—so much so that companies say they can no longer afford to provide it.
The women-focused telehealth brand Hers has launched a new weight loss membership program. The program provides access to GLP-1 medications, such as Ozempic and Wegovy, following a provider's ...
Fridays is a telehealth platform offering GLP-1 weight loss medications through a subscription model. The service provides both brand-name drugs like Ozempic and cheaper, non-FDA-approved compounded ...
Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...
NEW ORLEANS — The investigational triple GLP-1/GIP/glucagon receptor agonist retatrutide produced significant weight loss and A1c reduction in people with type 2 diabetes (T2D), according to full data ...
With the U.S. Food and Drug Administration (FDA) approving pill versions of orforglipron (Foundayo) and semaglutide (Wegovy) for weight management, you might wonder how the side effects of ...